Home › Anastomotic Leak › NCT07035431
Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery. * Subject is eligible for endoscopic intervention. * Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area. * Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity. * Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement. * Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study. * Investigator decision that EVT is the most suitable treatment of the available treatment options. Exclusion Criteria: * Subject is under 18 years of age. * Potentially vulnerable subject, including, but not limited to pregnant women. * Subject has undergone EVT or other similar interventions for the current colorectal indication. * Subject had colorectal surgery more than 60 days prior to the planned study procedure. * Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement. * Subject has known contraindication for EVT as per the IB. * Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.
About the study
This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.
What is being tested
- Endo-SPONGE (device)
Sponsor: Boston Scientific Corporation · Participants: 66 · Started: 2026-10
Contact the study team
- Steve Fodem · Phone: 651-246-3094
Official record on ClinicalTrials.gov — NCT07035431
Locations in the U.S.
| California | University of California, Davis Medical Center, Sacramento (Not yet recruiting) |
| Florida | Orlando Regional Medical Center, Orlando (Not yet recruiting) Cleveland Clinic Florida, Weston (Not yet recruiting) |
| Massachusetts | Lahey Medical Center, Burlington (Not yet recruiting) |
| New York | Mount Sinai, New York |
| Ohio | Cleveland Clinic Foundation, Cleveland (Not yet recruiting) |
| Pennsylvania | Penn State Health, Hershey Thomas Jefferson University Hospital, Philadelphia (Not yet recruiting) |
| Washington | University of Washington Medical Center, Seattle |
| West Virginia | Marshall University Medical Center, Huntington |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.